- Home
- XPEV vs ILMN Comparison
XPEV vs ILMN Comparison
Compare XPEV & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XPEV
- ILMN
- Stock Information
- Founded
- XPEV 2015
- ILMN 1998
- Country
- XPEV China
- ILMN United States
- Employees
- XPEV N/A
- ILMN N/A
- Industry
- XPEV Auto Manufacturing
- ILMN Medical Specialities
- Sector
- XPEV Consumer Discretionary
- ILMN Health Care
- Exchange
- XPEV Nasdaq
- ILMN Nasdaq
- Market Cap
- XPEV 21.7B
- ILMN 15.3B
- IPO Year
- XPEV 2020
- ILMN 2000
- Fundamental
- Price
- XPEV $22.43
- ILMN $121.90
- Analyst Decision
- XPEV Buy
- ILMN Hold
- Analyst Count
- XPEV 8
- ILMN 15
- Target Price
- XPEV $22.51
- ILMN $114.93
- AVG Volume (30 Days)
- XPEV 9.0M
- ILMN 2.1M
- Earning Date
- XPEV 11-17-2025
- ILMN 10-30-2025
- Dividend Yield
- XPEV N/A
- ILMN N/A
- EPS Growth
- XPEV N/A
- ILMN N/A
- EPS
- XPEV N/A
- ILMN 4.46
- Revenue
- XPEV $8,416,181,216.00
- ILMN $4,288,000,000.00
- Revenue This Year
- XPEV $99.25
- ILMN N/A
- Revenue Next Year
- XPEV $39.50
- ILMN $2.22
- P/E Ratio
- XPEV N/A
- ILMN $27.33
- Revenue Growth
- XPEV 66.37
- ILMN N/A
- 52 Week Low
- XPEV $11.14
- ILMN $68.70
- 52 Week High
- XPEV $27.16
- ILMN $155.99
- Technical
- Relative Strength Index (RSI)
- XPEV 49.67
- ILMN 66.82
- Support Level
- XPEV $21.36
- ILMN $118.50
- Resistance Level
- XPEV $24.90
- ILMN $126.00
- Average True Range (ATR)
- XPEV 0.97
- ILMN 5.02
- MACD
- XPEV 0.02
- ILMN 2.48
- Stochastic Oscillator
- XPEV 36.20
- ILMN 84.61
About XPEV XPeng Inc.
Founded in 2015, XPeng is a leading Chinese smart electric vehicle company that designs, develops, manufactures, and markets EVs in China. Its products primarily target the growing base of technology-savvy middle-class consumers in the midrange to high-end segment in China's passenger vehicle market. The company sold over 190,000 EVs in 2024, accounting for about 2% of China's passenger new energy vehicle market. It is also a leader in autonomous driving technology.
About ILMN Illumina Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.